HSBC interims beat expectations with 23% rise
HSBC posted a better-than-expected 23% jump in first-half profit driven by a strong second quarter on the back…
Relation Announces Expanded Collaboration with GSK
Up to $110 million upfront and success-based milestones collaboration will generate large-scale human cellular perturbation datasets to advance…
Glencore Announces Amendment and Restatement of Convertible Facilities Agreement With Tantalex Lithium Resources Corporation
NOT FOR DISSEMINATION IN THE UNITED STATES OR TO UNITED STATES NEWSWIRE SERVICES BAAR, Switzerland, July 17, 2026…
Astrazeneca strikes exclusive licensing deal with Dizal Pharmaceutical
Drugmaker Astrazeneca said on Tuesday that it has signed an exclusive licensing deal with Dizal Pharmaceutical for Zegfrovy,…
Haydale expands agreement with Lloyds Banking Group
Haydale said on Thursday that it had expanded its agreement with Lloyds Banking Group through its SaveMoneyCutCarbon platform,…
LinkShadow Expands Regional Footprint with e92Plus Distribution Partnership in the United Kingdom
LinkShadow Expands UK Presence with e92plus Distribution Partnership LONDON, UNITED KINGDOM, July 3, 2026 /EINPresswire.com/ — London, 3rd…
Andy Burnham “imagines” a new, decentralized United Kingdom with control over essential services
LondonThe United Kingdom has a new messiah. One more or a real one? Or perhaps just another politician,…
BP joins Abu Dhabi’s Bab Gas Cap project with 10pc stake
BP has signed a concession agreement with ADNOC and its partners to develop the Bab Gas Cap project…
YMCA of the USA Announces Plan to Expand Cancer Programs Nationwide with Multimillion Dollar AstraZeneca Partnership
CHICAGO, June 24, 2026 (GLOBE NEWSWIRE) — YMCA of the USA (Y-USA) announced a plan to expand and…
HSBC slapped with A$35m fine over Australia scam protection failures
HSBC has been fined AUD $35m after admitting it failed to protect Australian customers from being scammed out…
HSBC announces multi-year AI partnership with Google Cloud
HSBC announced a multi-year partnership with Google Cloud on Wednesday to build and deploy artificial intelligence capabilities across…
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Company remains on track for a planned December 2026 evaluation of the clinical trial’s primary endpoint OCALA, Fla.,…